Featured Article
Naegleria fowleri is common, deadly and there is no cure
Families and friends who lost a loved one to this devastating pathogen have found the strength and have the desire to inform other families of the risk and the prevention.
-
Leishmaniasis
- Regions: South America, Africa, Middle East, Asia, Southern Europe
- Afflicted: 12 million
- At Risk: 350 million
- Involved Since: 1997
-
Hookworm
- Regions: Sub-Saharan Africa, Central and South America, South and South-East Asia
- Afflicted: 0.7-1.0 billion
- At Risk: 1.0-1.2 billion
- Involved Since: 2010
-
Filariasis
- Regions: South America, Africa, Middle East, Asia, Southern Europe
- Afflicted: 12 million
- At Risk: 350 million
- Involved Since: 1997
-
African Sleeping Sickness
- Regions: Sub-Saharan Africa
- Afflicted: 50,000
- At risk: 60 million
- Involved Since: 1997
-
Schistosomiasis
- Regions: Africa, Middle East, Caribbean, South America, China, South East Asia
- Afflicted: 250 million
- At Risk: 700 million
- Involved Since: 1985
-
Onchocerciasis
- Regions: West and Central Africa, Yemen, Latin America.
- Afflicted: 25 million
- At Risk: 125 million
- Involved Since: 1990
-
Chagas Disease
- Regions: Latin America
- Afflicted: 7-8 million
- At risk: 100 million
- Involved Since: 1997
-
Naegleriasis
- Regions: Worldwide
- Afflicted: 235
- At Risk: Freshwater swimmers
- Involved Since: 1990
-
Amebiasis
- Regions: Central and South America, South Asia, Middle East, Africa Number
- Afflicted: 50 million
- At risk: 480 million
- Involved Since: 1985
Research
Neglected Tropical Diseases: from Innovation to Cure
Education
Hosting Scholars and Sabbaticals from Endemic Regions
Awareness
Striving for a Healthy World
Resources
• Screening • Validation • Design • Development
Contact Us
UCSD, Skaggs School of Pharmacy & Pharmaceutical Sciences,
9500 Gilman Dr. La Jolla California, 92093, USA